Is Roivant Sciences Ltd. (ROIV) a Strong Buy Amid Positive Clinical Trials and Strategic Partnerships? [Yahoo! Finance]
Roivant Sciences Ltd. (ROIV)
Company Research
Source: Yahoo! Finance
Rate Cuts Could Boost SMid-Cap Companies The Fed's decision to cut interest rates by 50 basis points in September significantly impacted the market. This decision, motivated by concerns about the labor market's health, is part of a broader plan to lower interest rates over the next few years. While some analysts believe a 50-basis point cut is too aggressive, others argue it could benefit small and mid-cap stocks. The Dow Jones Industrial Average also recently reached a new all-time high, indicating strong investor confidence. However, experts believe that small-cap stocks offer significant growth potential, and despite their recent underperformance compared to high-risk investments, small-cap stocks are expected to outperform large-cap stocks shortly. We went over the anticipated high returns from small-cap stocks in greater detail in one of our other articles, 10 Best Performing Small-Cap Stocks in 2024 , where we discussed Richard Bernstein's opinion, who is the CEO of Richa
Show less
Read more
Impact Snapshot
Event Time:
ROIV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ROIV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ROIV alerts
High impacting Roivant Sciences Ltd. news events
Weekly update
A roundup of the hottest topics
ROIV
News
- Biotech company nabs top two floors at Vornado's Penn 1 [Yahoo! Finance]Yahoo! Finance
- Is Roivant Sciences Ltd. (NASDAQ:ROIV) The Best NASDAQ Stock Under $50 To Buy? [Yahoo! Finance]Yahoo! Finance
- Roivant Sciences Ltd. (NASDAQ: ROIV) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Roivant Sciences Ltd. (NASDAQ: ROIV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.MarketBeat
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%GlobeNewswire
ROIV
Earnings
- 8/8/24 - Beat
ROIV
Sec Filings
- 10/1/24 - Form 4
- 9/26/24 - Form 4
- 9/26/24 - Form 4
- ROIV's page on the SEC website